Larsen And Toubro Declined By Over 3 Percent In Morning

Shares of Larsen and Toubro declined by over 3 percent in morning trade as investors reacted to Sebi denying permission for its buyback issue.

The engineering major on January 19 said market regulator Sebi denied permission for its Rs 9,000 crore share buyback offer.

The company has received approval from the United States Food & Drug Administration for an ANDA for 100mg and 400mg tablets of Imatinib Mesylate, which is used to treat many kinds of cancers and tumors.

For more information ✆ +91- 8349277146 or visit www.moneymarketmanthan.com